The company and all members of the board guarantee that the content of the information disclosure is true, accurate, and complete, without false records, misleading statements, or significant omissions.
Securities Code: 300878
Securities Abbreviation: Weikang Pharmaceutical
Announcement Number: 2026-028
Zhejiang Weikang Pharmaceutical Co., Ltd. (hereinafter referred to as "the Company") recently received a notification from its controlling shareholder and actual controller, Mr. Liu Zhongliang, regarding the pledge of part of his shares in the Company. The specific situation is as follows:
1. Basic Information on Share Pledge
1.1 Basic Situation of the Share Pledge
| Shareholder Name | Is Controlling Shareholder or Largest Shareholder | Pledged Shares (shares) | Proportion of Shares Held | Proportion of Total Share Capital | Is it Restricted Shares (if yes, specify type) | Is it Supplementary Pledge | Pledge Start Date | Pledge Expiry Date | Pledgee | Pledge Purpose |
|---|---|---|---|---|---|---|---|---|---|---|
| Liu Zhongliang | Yes | 5,500,000 | 6.24% | 3.80% | No | No | 2026/06/02 | Date of Pledge Release | Shanghai Aijian Trust Co., Ltd. | Personal funding needs |